Trial site
Chesapeake Urology Research Associates
Towson, Maryland 21204, United StatesNot linked to an institution yet
The trials here
What the 10 trials at this site are about, from their registry records.
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Recruiting4 trials
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Candel Therapeutics, Inc.1 trial
- Dendreon1 trial
- Nucleix Ltd.1 trial
- OncoC4, Inc.1 trial
- and 2 more
Running trials
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
NCT07332000· Phase 2· Candel Therapeutics, Inc.· Source
Contact: Tenia Heigh
Recruiting
Bladder EpiCheck Product Development Study
NCT07514143· Nucleix Ltd.· Source
Contact: Phelps
Active, not recruiting
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
NCT05682443· Phase 1/2· OncoC4, Inc.· Source
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
NCT06134232· Phase 2· Dendreon· Source
Contact: Ronald Tutrone, MD
Active, not recruiting
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
NCT05884398· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
NCT04114825· Phase 2· RhoVac APS· Source
Active, not recruiting
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT03431350· Phase 2· Janssen Research & Development, LLC· Source
Active, not recruiting
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837· Phase 3· Pfizer· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error